4//SEC Filing
HYPERION THERAPEUTICS INC 4
Accession 0001437749-15-002321
CIK 0001386858operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 9:37 PM ET
Size
8.0 KB
Accession
0001437749-15-002321
Insider Transaction Report
Form 4
Scharschmidt Bruce Frederick
SVP & Chief Medical Officer
Transactions
- Award
Common Stock
2015-02-09+14,000→ 97,471 total - Award
Employee Stock Option (right to buy)
2015-02-09+24,000→ 24,000 totalExercise: $25.97Exp: 2024-12-31→ Common Stock (24,000 underlying)
Holdings
- 54,248(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Each restricted stock unit represents a right to receive one share of Hyperion Therapeutics, Inc. common stock, subject to continued service.
- [F2]One-fourth of the total restricted stock units vest annually beginning January 1, 2016.
- [F3]Number of shares reflects adjustments made to correct mathematical errors made on Form 4 filed December 24, 2014.
- [F4]One-fourth of the shares underlying the option will vest and become exercisable beginning January 1, 2016, and the remaining three-fourths of the shares will vest monthly over the three years thereafter, subject to continued service.
Documents
Issuer
HYPERION THERAPEUTICS INC
CIK 0001386858
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001386858
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 9:37 PM ET
- Size
- 8.0 KB